{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:36:55Z","timestamp":1792784215060,"version":"4.5.0"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2013,7,1]],"date-time":"2013-07-01T00:00:00Z","timestamp":1372636800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"CUHK Direct Grant","award":["CUHK 2005.1.042"],"award-info":[{"award-number":["CUHK 2005.1.042"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2013,7]]},"DOI":"10.1016\/j.neuropharm.2013.01.013","type":"journal-article","created":{"date-parts":[[2013,1,25]],"date-time":"2013-01-25T16:46:34Z","timestamp":1359132394000},"page":"141-147","source":"Crossref","is-referenced-by-count":33,"special_numbering":"C","title":["Separation of emetic and anorexic responses of exendin-4, a GLP-1 receptor agonist in Suncus murinus (house musk shrew)"],"prefix":"10.1016","volume":"70","author":[{"given":"Sze Wa","family":"Chan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ge","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David Tai Wai","family":"Yew","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chi Kong","family":"Yeung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John A.","family":"Rudd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuropharm.2013.01.013_bib1","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1037\/h0077040","article-title":"Cholecystokinin elicits complete behavioral sequence of satiety in rats","volume":"89","author":"Antin","year":"1975","journal-title":"J.\u00a0Comp. Physiol. Psychol."},{"key":"10.1016\/j.neuropharm.2013.01.013_bib2","doi-asserted-by":"crossref","first-page":"R1243","DOI":"10.1152\/ajpregu.2001.281.4.R1243","article-title":"Plasma hormone levels and central c-Fos expression in ferrets after systemic administration of cholecystokinin","volume":"281","author":"Billig","year":"2001","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"key":"10.1016\/j.neuropharm.2013.01.013_bib3","doi-asserted-by":"crossref","first-page":"103","DOI":"10.7326\/0003-4819-154-2-201101180-00300","article-title":"Use of twice-daily exenatide in basal insulin-treated patients with type 2 diabetes a randomized, controlled trial","volume":"154","author":"Buse","year":"2011","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.neuropharm.2013.01.013_bib4","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.ejphar.2007.03.050","article-title":"Action of GLP-1 (7\u201336) amide and exendin-4 on Suncus murinus (house musk shrew) isolated ileum","volume":"566","author":"Chan","year":"2007","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2013.01.013_bib5","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.ejphar.2011.06.036","article-title":"A\u00a0physiological role of glucagon-like peptide-1 receptors in the central nervous system of Suncus murinus (house musk shrew)","volume":"668","author":"Chan","year":"2011","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2013.01.013_bib6","doi-asserted-by":"crossref","DOI":"10.1089\/dia.2011.0050","article-title":"Encapsulation of exenatide in poly-(d, l-lactide-co-glycolide) microspheres produced an investigational long-acting once-weekly formulation for type 2 diabetes","author":"Deyoung","year":"2011","journal-title":"Diabetes Technol. Ther."},{"key":"10.1016\/j.neuropharm.2013.01.013_bib7","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1172\/JCI990","article-title":"Glucagon-like peptide 1 promotes satiety and suppresses energy intake in humans","volume":"101","author":"Flint","year":"1998","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.neuropharm.2013.01.013_bib8","series-title":"The Mouse Brain in Stereotaxic Coordinates","author":"Frankin","year":"2008"},{"key":"10.1016\/j.neuropharm.2013.01.013_bib9","doi-asserted-by":"crossref","first-page":"2294","DOI":"10.1111\/j.1460-9568.1995.tb00650.x","article-title":"Distribution of GLP-1 binding sites in the rat brain: evidence that exendin-4 is a ligand of brain GLP-1 binding sites","volume":"7","author":"Goke","year":"1995","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.neuropharm.2013.01.013_bib10","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1111\/j.1476-5381.2009.00176.x","article-title":"Opportunities for the replacement of animals in the study of nausea and vomiting","volume":"157","author":"Holmes","year":"2009","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2013.01.013_bib11","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1002\/cne.902710405","article-title":"Distribution of glucagonlike peptide-I (Glp-I), glucagon, and glicentin in the rat-brain \u2013 an immunocytochemical study","volume":"271","author":"Jin","year":"1988","journal-title":"J.\u00a0Comp. Neurol."},{"key":"10.1016\/j.neuropharm.2013.01.013_bib12","doi-asserted-by":"crossref","first-page":"1916","DOI":"10.1016\/j.neuropharm.2011.12.022","article-title":"The role of nausea in food intake and body weight suppression by peripheral GLP-1 receptor agonists, exendin-4 and liraglutide","volume":"62","author":"Kanoski","year":"2012","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2013.01.013_bib13","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1267\/ahc.24.465","article-title":"Immunocytochemical localization of monoaminergic and non-aminergic neurones of the house-shrew (Sucnus murinus) brain","volume":"24","author":"Karasawa","year":"1991","journal-title":"Acta Histochem. Cytochem."},{"key":"10.1016\/j.neuropharm.2013.01.013_bib14","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1016\/S0140-6736(87)91194-9","article-title":"Glucagon-like peptide-1 7\u201336: a physiological incretin in man","volume":"2","author":"Kreymann","year":"1987","journal-title":"Lancet"},{"key":"10.1016\/j.neuropharm.2013.01.013_bib15","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/S0306-4522(96)00434-4","article-title":"Distribution of glucagon-like peptide-1 and other preproglucagon-derived peptides in the rat hypothalamus and brainstem","volume":"77","author":"Larsen","year":"1997","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2013.01.013_bib16","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1097\/00008877-200512000-00002","article-title":"Action of ondansetron and CP-99,994 on cisplatin-induced emesis and locomotor activity in Suncus murinus (house musk shrew)","volume":"16","author":"Lau","year":"2005","journal-title":"Behav. Pharmacol."},{"key":"10.1016\/j.neuropharm.2013.01.013_bib17","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/S0014-2999(02)01434-6","article-title":"Glucagon-like peptide 1 as a regulator of food intake and body weight: therapeutic perspectives","volume":"440","author":"Meier","year":"2002","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2013.01.013_bib18","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1002\/(SICI)1096-9861(19990111)403:2<261::AID-CNE8>3.0.CO;2-5","article-title":"Distribution of pre-pro-glucagon and glucagon-like peptide-1 receptor messenger RNAs in the rat central nervous system","volume":"403","author":"Merchenthaler","year":"1999","journal-title":"J.\u00a0Comp. Neurol."},{"key":"10.1016\/j.neuropharm.2013.01.013_bib19","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1113\/expphysiol.2012.066472","article-title":"The dorsal motor nucleus of the vagus and regulation of pancreatic secretory function","volume":"98","author":"Mussa","year":"2013","journal-title":"Exp. Physiol."},{"key":"10.1016\/j.neuropharm.2013.01.013_bib20","doi-asserted-by":"crossref","first-page":"A1168","DOI":"10.1016\/S0016-5085(98)84749-5","article-title":"Glucagon-like peptide-1 (GLP-1) increases satiety and slows gastric emptying in obese people","volume":"114","author":"Naslund","year":"1998","journal-title":"Gastroenterology"},{"key":"10.1016\/j.neuropharm.2013.01.013_bib21","doi-asserted-by":"crossref","first-page":"12826","DOI":"10.1016\/S0021-9258(18)51561-1","article-title":"Complete sequences of glucagon-like peptide-1 from human and pig small intestine","volume":"264","author":"Orskov","year":"1989","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.neuropharm.2013.01.013_bib22","doi-asserted-by":"crossref","first-page":"143","DOI":"10.2337\/db05-0996","article-title":"Exendin-4 potently decreases ghrelin levels in fasting rats","volume":"56","author":"Perez-Tilve","year":"2007","journal-title":"Diabetes"},{"key":"10.1016\/j.neuropharm.2013.01.013_bib23","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1177\/0091270010367653","article-title":"Effect of administration time of exenatide on satiety responses, blood glucose, and adverse events in healthy volunteers","volume":"51","author":"Pinelli","year":"2011","journal-title":"J.\u00a0Clin. Pharmacol."},{"key":"10.1016\/j.neuropharm.2013.01.013_bib24","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/0006-8993(91)91654-J","article-title":"Cisplatin-evoked induction of c-fos protein in the brainstem of the ferret: the effect of cervical vagotomy and the anti-emetic 5-HT3 receptor antagonist granisetron (BRL 43694)","volume":"565","author":"Reynolds","year":"1991","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2013.01.013_bib25","first-page":"R1537","article-title":"A\u00a0functional role for central glucagon-like peptide-1 receptors in lithium chloride-induced anorexia","volume":"277","author":"Rinaman","year":"1999","journal-title":"Am. J. Physiol."},{"key":"10.1016\/j.neuropharm.2013.01.013_bib26","first-page":"R582","article-title":"Interoceptive stress activates glucagon-like peptide-1 neurons that project to the hypothalamus","volume":"277","author":"Rinaman","year":"1999","journal-title":"Am. J. Physiol."},{"key":"10.1016\/j.neuropharm.2013.01.013_bib27","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/S0014-2999(01)01041-X","article-title":"Genital grooming and emesis induced by vanilloids in Suncus murinus, the house musk shrew","volume":"422","author":"Rudd","year":"2001","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2013.01.013_bib28","first-page":"A1186","article-title":"Exendin(9\u201339)amide is a potent specific antagonist of glucagon-like peptide-1(7\u201336)amide in humans","volume":"112","author":"Schirra","year":"1997","journal-title":"Gastroenterology"},{"key":"10.1016\/j.neuropharm.2013.01.013_bib29","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/0006-8993(94)01421-D","article-title":"c-Fos induction in response to taste stimuli previously paired with amphetamine or LiCl during taste aversion learning","volume":"673","author":"Swank","year":"1995","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2013.01.013_bib30","first-page":"R848","article-title":"Central administration of GLP-1-(7\u201336) amide inhibits food and water intake in rats","volume":"271","author":"Tang-Christensen","year":"1996","journal-title":"Am. J. Physiol."},{"key":"10.1016\/j.neuropharm.2013.01.013_bib31","first-page":"R726","article-title":"Central infusion of GLP-1, but not leptin, produces conditioned taste aversions in rats","volume":"272","author":"Thiele","year":"1997","journal-title":"Am. J. Physiol."},{"key":"10.1016\/j.neuropharm.2013.01.013_bib32","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1038\/379069a0","article-title":"A\u00a0role for glucagon-like peptide-1 in the central regulation of feeding","volume":"379","author":"Turton","year":"1996","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2013.01.013_bib33","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/0024-3205(87)90229-3","article-title":"Suncus murinus: a new experimental model in emesis research","volume":"41","author":"Ueno","year":"1987","journal-title":"Life Sci."},{"key":"10.1016\/j.neuropharm.2013.01.013_bib34","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1038\/385214a0","article-title":"Glucagon-like peptide-1 and satiety","volume":"385","author":"Van Dijk","year":"1997","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2013.01.013_bib35","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S0165-1838(98)00062-9","article-title":"Brainstem origin of the efferent components of the cervical vagus nerve in the house musk shrew, Suncus murinus","volume":"71","author":"Won","year":"1998","journal-title":"J.\u00a0Anat. Nerv. Syst."},{"key":"10.1016\/j.neuropharm.2013.01.013_bib36","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1677\/joe.1.05866","article-title":"Appetite control","volume":"184","author":"Wynne","year":"2005","journal-title":"J.\u00a0Endocrinol."},{"key":"10.1016\/j.neuropharm.2013.01.013_bib37","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.physbeh.2004.08.006","article-title":"Differential activity of drugs to induce emesis and pica behaviour in Suncus murinus (house musk shrew) and rats","volume":"83","author":"Yamamoto","year":"2004","journal-title":"Physiol. Behav."},{"key":"10.1016\/j.neuropharm.2013.01.013_bib38","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/S0028-3908(99)00113-6","article-title":"The effect of the NK1 receptor antagonist CP-99,994 on emesis and c-fos protein induction by loperamide in the ferret","volume":"39","author":"Zaman","year":"2000","journal-title":"Neuropharmacology"}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390813000300?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390813000300?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,2,6]],"date-time":"2022-02-06T15:50:41Z","timestamp":1644162641000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390813000300"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,7]]},"references-count":38,"alternative-id":["S0028390813000300"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2013.01.013","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2013,7]]}}}